Conference Coverage

Clinical advances drive lung cancer staging, classification changes


 

AT THE IASLC WORLD CONFERENCE

References

The proposed revision would continue to group in the M1a category cases with pleural/pericardial effusions, contralateral/bilateral lung nodules, contralateral/bilateral pleural nodules, or a combination of multiple parameters. However, single metastatic lesions in a single distant organ would be reclassified as M1b, and multiple lesions in a single organ or multiple lesions in multiple organs would be reclassified as M1c.

Pages

Recommended Reading

AATS: No postpneumonectomy survival benefit in adding radiation to chemotherapy for NSCLC
MDedge Surgery
ASCO: Precision medicine initiatives take wing
MDedge Surgery
Contrast imaging detects some lung tumors in surgery
MDedge Surgery
Invasive approaches ‘overused’ for evaluating pulmonary nodules
MDedge Surgery
AATS: Metformin linked to better progression-free survival in early-stage NSCLC
MDedge Surgery
Limited resection inferior for elderly with early NSCLC
MDedge Surgery
Solid histology predicts poor survival in resected lung adenocarcinoma
MDedge Surgery
Surgeon volume may affect choice of surgery type for NSCLC
MDedge Surgery
Share of lung cancer patients who never smoked is rising
MDedge Surgery
New cancer cases to reach nearly 2.4 million in 2035 – AACR
MDedge Surgery